That's why users report gradual fading over 34 weeks post-cycle rather than immediate loss of pigmentation
Purpose-built for physicians GLP-1, SGLT2 combination therapy provides largest weight loss for women with PCOS Combination therapy with a GLP-1 receptor agonist and an SGLT2 inhibitor may provide better weight-loss benefits than a single agent for women with polycystic ovary syndrome and obesity, according to study data
1,2,3 These processes continue to play essential roles in bone growth, repair, and regeneration throughout life
Thats not a decision to make alone
If you are switching from a daily to a weekly dosage, you can take the first dose of the new medication the next day
Ann N Y Acad Sci 1019:346349 Richman PG, Meister A (1975) Regulation of gamma-glutamyl-cysteine synthetase by nonallosteric feedback inhibition by glutathione